This site is intended for healthcare professionals
Anti-platelet hero
Antiplatelet therapy in ACS: Choices and Controversies

ESC 2022 Highlights

Read time: 10 mins
Last updated:22nd Sep 2022
Published:2nd Nov 2022

The latest in Acute Coronary Syndrome from ESC 2022

From the 2022 European Society of Cardiology (ESC) congress in Barcelona, receive original content on developments in acute coronary syndrome (ACS) treatments, focusing on international guideline updates, and antiplatelet therapies such as P2Y12 inhibitors.

To receive the latest developments from ESC 2022, register for a free Medthority account today, or log into your existing account

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

To receive the latest developments from ESC 2022, register for a free Medthority account today, or log into your existing account

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

To receive the latest developments from ESC 2022, register for a free Medthority account today, or log into your existing account

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

To receive the latest developments from ESC 2022, register for a free Medthority account today, or log into your existing account

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Welcome: